|
|
Expression and Significance of C-erbB-2 and NuSAP1 in Triple Negative Breast Cancer with Axillary Lymph Node Metastasis |
LIU Xianghua, LV Yonggang, MENG Qingjie, et al |
The Affiliated Hospital of Northwest University / Xi'an Third Hospital, Shaanxi Xi'an, 710000 |
|
|
Abstract Objective: To investigate the expression of epidermal growth factor receptor 2 (C-erbB-2) and nuclear spindle associated protein 1 (NuSAP1) in tumor tissues and paracancer tissues of triple negative breast cancer patients with axillary lymph node metastasis and to analyze their significance. Methods: Clinical data of 150 breast cancer patients treated in our hospital from July 2016 to October 2020 were retrospectively selected, and the patients were divided into observation group (triple negative breast cancer) and control group (non triple negative breast cancer) according to immunohistochemistry, with 49 cases in observation group and 101 cases in control group. The expression levels of C-erbB-2 and NuSAP1 were compared between the two groups, and their relationship with axillary lymph node metastasis was analyzed. Results: The high expression rate of C-erbB-2 in observation group was 87.76%, which was significantly higher than that in control group (63.37%) (P<0.05). The positive high expression rate of NuSAP1 in observation group was 79.59%, which was significantly higher than that in control group (61.39%) (P<0.05). Among the 49 patients with triple negative breast cancer, 22 had no axillary lymph node metastasis and 27 had axillary lymph node metastasis. The axillary lymph node metastasis rate of c-erbB-2 and NuSAP1 high expression group was significantly higher than that of low expression group (P<0.05). Conclusion: The positive overexpression rate of C-erbB-2 and NuSAP1 in triple negative breast cancer is higher than that in non triple negative breast cancer, and the positive overexpression rate of C-erbB-2 and NuSAP1 in axillary lymph node metastasis is significantly higher than that in non-axillary lymph node metastasis, which may be a new prognostic indicator.
|
|
|
|
|
[1] 李贺,郑荣寿,张思维,等.2014年中国女性乳腺癌发病与死亡分析[J].中华肿瘤杂志,2018,40(3):166~171. [2] 范东伟,姚昌洋,姚廷敬.三阴性乳腺癌的研究进展[J].医学综述,2018,24(1):77~81. [3] 刘蕾,张瑾.三阴性乳腺癌靶向治疗研究进展[J].天津医药,2018,46(12):1363~1367. [4] 王阿军,章斌.乳腺癌超声特征与分子分型相关性研究进展[J].中国血液流变学杂志,2018,28(1):112~115. [5] 王金文,文秋元,李弘夏,等.核仁纺锤体相关蛋白在恶性肿瘤中作用的研究进展[J].临床与实验病理学杂志,2019,35(12):64~67. [6] 李甜,周钱梅,张卫红.PI3K/Akt/mTOR信号通路在三阴性乳腺癌治疗中的研究进展[J].中国肿瘤,2018,27(1):40~45. [7] 孙晓萌,高社干.三阴性乳腺癌的临床治疗现状及新进展[J].实用癌症杂志,2020,219(6):171~173. [8] 徐兵河,王树森,江泽飞,等.中国晚期乳腺癌维持治疗专家共识[J].中华普通外科学文献(电子版),2018,12(1):7~11. [9] 蒋梦怡,陆言巧,王红霞.乳腺癌异质性的研究进展及临床意义[J].中国癌症杂志,2020,247(5):79~85. [10] 徐平,杨敏,刘勇,等.C-erbB-2和Ki-67表达阳性及阴性的乳腺癌超声造影定性及定量参数对比观察[J].山东医药,2020,60(30):57~59. [11] 闫佩毅,袁亚,张骥,等.乳腺癌C-erbB-2基因启动子区CpG岛的甲基化状态与雄激素受体表达的相关性分析[J].检验医学,2018,33(6):89~95. [12] 靳凤梅,王惠,马苏美,等.乳腺癌ABVS表现与ER、PR、Her-2及Ki67的相关性研究[J].中国超声医学杂志,2018,328(2):115~119. [13] 张顺礼,王雅琪,胡继卫,等.乳腺癌组织中核仁纺缍体相关蛋白1表达与腋窝淋巴结转移的关系[J].肿瘤学杂志,2020,218(11):33~37. [14] Liu Z,Guan C,Lu C,et al.High NUSAP1 expression predicts poor prognosis in colon cancer[J].Pathol Res Pract,2018,214(7):968~973. [15] Xu Z,Wang Y,Xiong J,et al.NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling[J].Cell Physiol,2020,235(4):3886~3893. |
|
|
|